Recon: FDA Puts CRISPR Trial on Hold – Regulatory Focus
Regulatory Focus |
Recon: FDA Puts CRISPR Trial on Hold
Regulatory Focus Gene-Therapy Company Crispr Drops as FDA Puts Trial on Hold (Bloomberg-$) (Xconomy) (Boston Business Journal-$) (Endpoints) (BioPharma Dive); Minnesota sues opioid maker Insys over improper drug marketing (Reuters) (Minneapolis Star Tribune) … |
